New HIV drug tested in First-Time patients

NCT ID NCT06061081

Terminated Disease control Sponsor: ViiV Healthcare Source: ClinicalTrials.gov ↗

Summary

This study tested a new drug called VH3739937 in adults with HIV who had never taken antiviral medication before. The main goal was to see how well it reduced the amount of virus in the blood and to check its safety. The trial was small, ended early, and participants were expected to start standard combination therapy after a short period of testing the new drug alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Bakersfield, California, 93301, United States
GSK Investigational Site

Miami, Florida, 33136, United States
GSK Investigational Site

Dallas, Texas, 75246, United States
GSK Investigational Site

Buenos Aires, C1181ACH, Argentina
GSK Investigational Site

Rosario, 2000, Argentina
GSK Investigational Site

Athens, 12462, Greece
GSK Investigational Site

Brescia, 25123, Italy
GSK Investigational Site

Genova, 16132, Italy
GSK Investigational Site

Milan, 20142, Italy
GSK Investigational Site

Roma, 00133, Italy
GSK Investigational Site

Warsaw, 01-201, Poland
GSK Investigational Site

A Coruña, 15006, Spain
GSK Investigational Site

Alicante, 03010, Spain
GSK Investigational Site

Granada, 18014, Spain
GSK Investigational Site

Jerez de la Frontera, 11407, Spain
GSK Investigational Site

Madrid, 28006, Spain
GSK Investigational Site

Madrid, 28222, Spain
GSK Investigational Site

Vitoria-Gasteiz, 1009, Spain

Conditions

Explore the condition pages connected to this study.

HIV INFECTIONS